glp-1 microdosing for menopause Drugs GLP-1 Microdosing for Perimenopause and

The eligibility criteria included any case report or case series that documented instances of AP during the administration of GLP-1 RAs

Through its antioxidant properties, glutathione helps to counteract the activity of enzymes involved in melanin synthesis, particularly tyrosinase

H 2 DCFDA is a nonfluorescent ester of the dye fluorescein that is cleaved by intracellular esterases and is entrapped within the cell as the oxidant sensitive DCF compound

Before starting, we review mood stability, current medications, eating history, sleep, and where you are in the menopause transition

We will either order labs for you or accept labs completed within 6 months prior to program enrollment